|
Health |
|
Nutrition labels for a variety of packaged food products. Photo: Getty Images/iStock
|
|
|
Do you want dihydrogen monoxide in your food? The food industry is grappling with consumer - and executive - demands to remove chemicals from products. Some food scientists say they're being asked to remove ingredients just because they sound strange, Annie Gasparro and Heather Haddon report. It took two years for Conagra to find a replacement for mono- and diglycerides to thicken its Marie Callender's frozen chicken Alfredo pasta.
Do some ingredients need better PR? Anna Abram, an FDA deputy commissioner, points to vitamin B12, which in line with FDA regulations appears on some food labels as cyanocobalamin. “That sounds like cyanide,” she says. Dihydrogen monoxide, some wags note, is water.
How closely do you read food labels, and do you always understand what you're reading? Share your thoughts by responding to this email.
– Stefanie Ilgenfritz, Health & Science Bureau Chief, WSJ
Reach me at stefanie.ilgenfritz@wsj.com or Twitter: @stefaniei
|
|
|
|
Babies’ Sleep Linked to Lower Obesity Risks Years Later. Newborns whose parents were taught to help them sleep better were less likely to be overweight in childhood, researchers found. Sumathi Reddy explains in Your Health.
|
|
|
Do You Buy Your Own Scrubs? Figs, a five-year-old startup is targeting the stodgy medical-apparel industry with direct-to-consumer "premium" scrubs. This year, it’s on track to make $100 million in revenue
|
|
|
Questioning Hospital Watchdogs. Death rates at hospitals inspected by federally approved groups such as the Joint Commission were no better than at other facilities, a Harvard study found. The report follows a report in The Wall Street Journal that problem-plagued facilities routinely kept their Joint Commission accreditation.
|
|
|
|
|
"Patent Thicket" Blocks Humira Biosimilars in U.S. Cheaper copies of the world’s biggest-selling drug are rolling out across Europe this week after a key patent expired, but in the U.S., Humira maker AbbVie has taken out more than 100 patents, and sued to block or delay rivals' biosimilars. Critics say the tactic delays savings for patients.
|
|
Industry Pushes Back on Requiring Drug Prices in Ads. The Pharmaceutical Research and Manufacturers of America trade group said major drugmakers' TV ads would direct consumers to websites for more information on drug costs--well short of the proposal from the Trump administration to require disclosure of list prices.
|
|
|
|
Opioid Makers Seek Proof of Harm in Lawsuits: Purdue Pharma and other drugmakers being sued by municipalities and counties are pushing their adversaries to point to prescriptions that shouldn't have been written, and specific patients harmed.
|
|
Novartis to Buy Endocyte for $2.1 Billion: The deal expands Novartis's portfolio of so-called radiopharmaceuticals, a new class of drug that carries radioactive substances directly to cancer cells so they can kill tumor cells at close range.
|
|
|
|
$423 Million |
The amount Innovent Biologics is trying to raise in an IPO on the Hong Kong stock exchange, despire poor performance of other biotechs listed in the city. (Read more)
|
|
|
|
| Surviving Long-Haul Flights |
|
|
|
Are We There Yet? For this advice-packed video, columnist Scott McCartney went nonstop from Newark, N.J., to Singapore, testing his do's and don'ts for avoiding the headaches, fatigue and other ills that come with 18 hours on a plane. (Tip No. 1: Hydrate.) As he points out in his accompanying The Middle Seat column, even travelers who think they’ve seen it all need a plan to endure flying to the other side of the planet.
|
|
|
“PhRMA remains concerned that just including list prices in these advertisements is not sufficient and could discourage patients from seeking needed medical care."
| — Pharmaceutical Research and Manufacturers of America, in response to the Trump administration proposal to require drug prices in ads. |
|
|
|
|
-
WHO Calls for More Resources to Fight Ebola Outbreak (Read more)
-
Cases of Rare Neurological Condition Rise in U.S. (Read more)
-
Republican Candidates Play Defense Over Health Care (Read more)
-
Prescription Drugs Power Johnson & Johnson Results (Read more)
-
UnitedHealth Raises Full-Year Earnings Projection (Read more)
|
|
|
LEAVE THIS BOX EMPTY |
|